Attached files

file filename
10-K - 10-K - AMGEN INCamgn-12312017x10k.htm
EX-32 - SECTION 1350 CERTIFICATIONS - AMGEN INCamgn-ex32_20171231xq4.htm
EX-31 - RULE 13A-14(A) CERTIFICATIONS - AMGEN INCamgn-ex31_20171231xq4.htm
EX-10.11 - FORM OF CASH-SETTLED RSU AGREEMENT FOR DIRECTOR PROGRAM - AMGEN INCexhibit1011formofcashsettl.htm
EX-10.10 - FORM OF RSU AGREEMENT FOR DIRECTOR PROGRAM - AMGEN INCexhibit1010formofrestricte.htm
EX-10.8 - AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM - AMGEN INCexhibit108amgeninc2009dire.htm
EX-10.7 - FORM OF GLOBAL PERFORMANCE UNIT AGREEMENT - AMGEN INCexhibit107formofperformanc.htm
EX-10.6 - AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM - AMGEN INCexhibit106performanceaward.htm
EX-10.5 - FORM OF GLOBAL RSU AGREEMENT - AMGEN INCexhibit105formofrestricted.htm
EX-10.4 - FORM OF GLOBAL STOCK UNIT AGREEMENT - AMGEN INCexhibit104formofstockoptio.htm
Exhibit 21

AMGEN INC.

The following is a list of subsidiaries of the Company as of December 31, 2017, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary.    
 
 
 
 
 
 
SUBSIDIARY
 
STATE OF OTHER JURISDICTION OF
(Name under which subsidiary does business)
 
INCORPORATION OR ORGANIZATION
 
 
 
Amgen (Europe) GmbH
 
Switzerland
Amgen Fremont Inc.
 
Delaware
Amgen Global Finance B.V.
 
Netherlands
Amgen Holding No. 1
 
Bermuda
Amgen Manufacturing, Limited
 
Bermuda
Amgen Rockville, Inc.
 
Delaware
Amgen SF, LLC
 
Delaware
Amgen Technology (Ireland)
 
Ireland
Amgen Technology, Limited
 
Bermuda
Amgen USA Inc.
 
Delaware
Amgen Worldwide Holdings B.V.
 
Netherlands
ATL Holdings Limited
 
Bermuda
ATL Holdings II Limited
 
Bermuda
BioVex, Inc.
 
Delaware
Immunex Corporation
 
Washington
Immunex Rhode Island Corporation
 
Delaware
Onyx Pharmaceuticals, Inc.
 
Delaware
Onyx Therapeutics, Inc.
 
Delaware